First in human study BIOMAG-I: 12 months results of the sirolimus eluting resorbable coronary magnesium scaffold system (DREAMS 3G) in the treatment of subjects with de novo coronary artery lesions

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes in clinical practice: miscellaneous Clinical ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by